Results 91 to 100 of about 5,950 (190)

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis [PDF]

open access: yes, 2013
Background: At the time of approval of a new medicine, there are few long-term data on the medicine's benefit-risk balance. Clinical trials are designed to demonstrate efficacy, but have major limitations with regard to safety in terms of patient ...
Boer, A.C. (Anton) de   +5 more
core   +1 more source

Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn’s disease [PDF]

open access: yes, 2015
Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic, relapsing inflammatory bowel diseases associated with significant morbidity. Conventional therapies for these diseases include corticosteroids, aminosalicylates, immunomodulators, and ...
Biogen Idec Inc   +6 more
core   +2 more sources

Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study

open access: yesVaccine: X
In Veneto Region, HPV vaccine has been actively offered to 12 year-old females since 2008, and to 12 year-old males since 2015. The study aims to analyze the safety profile of HPV4v and HPV9v vaccines and perform a case-by-case review of conditions of ...
Diana Dalla Valle   +13 more
doaj   +1 more source

Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures [PDF]

open access: yes, 2015
Immunocompromised patients are traveling at increasing rates. Physicians caring for these complex patients must be knowledgeable in pretravel consultation and recognize when referral to an infectious disease specialist is warranted. This article outlines
Koolwal, Pooja   +3 more
core   +2 more sources

Individualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice

open access: yesDrug, Healthcare and Patient Safety, 2015
Olaf GJ Naether,1 Andreas Tandler-Schneider,2 Wilma Bilger3 1Reproductive Endocrinology, MVZ Fertility Center Hamburg, Hamburg, 2Center for Reproductive Medicine, Fertility Center Berlin, Berlin, 3Medical Affairs, Fertility, Endocrinology and General ...
Naether OGJ   +2 more
doaj  

Considering the New REMS Legislation of the 2007 Amendments [PDF]

open access: yes, 2012
On September 27, 2007, the Congress passed new amendments to the Food, Drug and Cosmetic Act. These amendments contained numerous changes to the act aimed at addressing the current needs for food, drug, and cosmetic safety. Yet, arguably one area of that
Walker, Petal
core  

Biosimilars: potential implications for clinicians

open access: yesClinical, Cosmetic and Investigational Dermatology, 2016
Misty G Eleryan,1 Sophia Akhiyat,2 Monica Rengifo-Pardo,1 Alison Ehrlich,1,2 1Department of Dermatology, The George Washington Medical Faculty Associates, 2George Washington University School of Medicine & Health Sciences, Washington, DC, USA ...
Eleryan MG   +3 more
doaj  

A Proactive Approach to Womens Concerns: Womens Longevity Groups and Funds [PDF]

open access: yes, 2005
With the exception of ten countries in the world, according to the World Health Organization's 2005 report, women outlive men. In the United States, women outlive men by 5.3 years.
Myrna I. Lewis
core  

\u3ci\u3ePLIVA v. Mensing\u3c/i\u3e and Its Implications [PDF]

open access: yes, 2011
The U.S. Supreme Court ruling in PLIVA Inc. v. Mensing will immunize generic drug manufacturers facing failure-to-warn claims from state-law liability, and may also have implications for preemption jurisprudence more generally, says attorney Brian ...
Feldman, Dena, Wolfman, Brian
core   +1 more source

Caracterización de las reacciones adversas medicamentosas en ancianos. Matanzas. 2005-2009 Characterization of the adverse drug reactions in elder people. Matanzas. 2005-2009

open access: yesRevista Médica Electrónica, 2011
La presente investigación caracterizó las notificaciones de sospechas de reacciones adversas medicamentosas en personas mayores de 60 años, recibidas en la Unidad Coordinadora Provincial de Farmacovigilancia, desde el 1 de enero de 2005 al 31 de ...
Leidy Santos Muñoz   +1 more
doaj  

Home - About - Disclaimer - Privacy